+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Image-guided Therapy System Market by Product, Imaging Modality, Therapy Type, Application, End User - Global Forecast 2026-2032- Product Image
Image-guided Therapy System Market by Product, Imaging Modality, Therapy Type, Application, End User - Global Forecast 2026-2032- Product Image
Sale

Image-guided Therapy System Market by Product, Imaging Modality, Therapy Type, Application, End User - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904904
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Image-guided Therapy System Market is projected to reach USD 5.53 Billion in 2026. It is expected to continue growing at a CAGR of 7.67%, reaching USD 8.64 Billion by 2032.

Image-guided therapy systems are becoming core infrastructure for minimally invasive care, combining real-time imaging, navigation software, interventional devices, procedure planning, and increasingly robotics-enabled execution. Demand is supported by the global burden of cancer, cardiovascular disease, stroke, and musculoskeletal disorders, with the World Health Organization attributing roughly three-quarters of global deaths to noncommunicable diseases.

For hospitals and ambulatory procedure centers, the value proposition is clear: image-guided therapy can improve procedural precision, reduce open-surgery exposure, shorten recovery pathways, and expand access to complex interventions across interventional radiology, cardiology, oncology, neurosurgery, orthopedics, and vascular care. As health systems prioritize productivity and outcomes, image-guided therapy system adoption is increasingly tied to digital workflow integration, cybersecurity, interoperability, radiation dose management, and total cost of ownership.

Transformative Shifts in the Image-Guided Therapy Landscape

The image-guided therapy landscape is shifting from standalone imaging rooms toward connected, software-defined procedural environments. Hybrid operating rooms, advanced angiography suites, cone-beam CT, intraoperative ultrasound, MRI guidance, and electromagnetic navigation are converging with electronic health records, PACS, and cloud-based analytics to support faster decision-making.

A major transformation is the movement from volume-based capital procurement to value-based technology assessment. Providers are evaluating systems on procedure throughput, radiation dose optimization, staff utilization, clinical versatility, upgradeability, and compatibility with artificial intelligence. At the same time, demographic aging, expanding cancer screening, growth in structural heart and neurovascular procedures, and rising demand for day-care interventions are reshaping purchasing priorities across mature and emerging healthcare systems.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the capabilities of image-guided therapy systems by improving segmentation, lesion detection, instrument tracking, registration, dose management, scheduling, and procedural documentation. The U.S. Food and Drug Administration public list of AI/ML-enabled medical devices surpassed 950 authorized devices by late 2024, with radiology representing the largest category, demonstrating strong regulatory momentum for imaging-led clinical AI.

The cumulative impact is moving beyond image interpretation into procedural intelligence. AI can help standardize workflows, reduce variability among operators, support predictive maintenance, and generate structured data for quality reporting. However, industry leaders must address model validation, bias, cybersecurity, explainability, clinical oversight, and post-market monitoring to ensure AI-enabled image-guided therapy improves outcomes without increasing operational or regulatory risk.

Key Regional Insights

North America remains a leading region for image-guided therapy system adoption due to high procedure volumes, strong reimbursement for advanced interventions, extensive hospital networks, and early adoption of AI-enabled imaging. The United States and Canada also benefit from established interventional radiology, cardiology, oncology, and neurosurgery programs, alongside quality reporting requirements that reinforce demand for connected imaging and procedural data systems.

Europe continues to benefit from universal healthcare coverage, established interventional radiology and cardiology capacity, and procurement policies that increasingly emphasize evidence, sustainability, cybersecurity, and interoperability. The region’s regulatory environment supports careful technology evaluation, while aging populations and cancer and cardiovascular disease burdens sustain the need for minimally invasive image-guided procedures.

Asia-Pacific is one of the most dynamic regions, supported by healthcare infrastructure expansion in China, India, Japan, South Korea, Australia, and ASEAN markets. Japan’s aging population, China’s large hospital network modernization, India’s private hospital expansion, and Australia and South Korea’s advanced specialty care ecosystems are reinforcing adoption of image-guided therapy platforms across oncology, vascular, cardiac, and orthopedic interventions.

Latin America, led by Brazil and Mexico, is investing in tertiary care modernization while managing affordability constraints, uneven specialist distribution, and public-private access gaps. The Middle East is accelerating specialty hospital development through national health transformation programs, particularly in oncology, cardiovascular care, and digital hospitals. Africa presents long-term opportunity as imaging capacity, cancer care access, health workforce training, and referral networks expand, though capital availability and maintenance infrastructure remain decisive adoption factors.

Key Group Insights

Within ASEAN, rising medical tourism, private hospital investment, and urban healthcare modernization are supporting demand for advanced image-guided therapy systems, although procurement varies significantly by country income level, reimbursement structure, and specialist availability. Demand is strongest where tertiary hospitals are expanding cardiovascular, oncology, and minimally invasive surgery programs, while long-term adoption depends on training, service support, and affordability.

The GCC is investing in digitally enabled hospitals, oncology centers, and cardiovascular programs aligned with national health diversification strategies, creating favorable conditions for hybrid operating rooms, advanced imaging suites, and AI-supported clinical workflows. The European Union is shaped by Medical Device Regulation compliance, cross-border quality standards, health technology assessment, and growing demand for interoperable, energy-efficient systems that can integrate with national digital health infrastructure.

BRICS markets combine large patient populations with uneven infrastructure, making scalable service models, local regulatory pathways, domestic manufacturing support, and clinical training critical for adoption. G7 countries remain technology trendsetters because of research intensity, specialist density, advanced reimbursement mechanisms, and earlier use of AI-enabled imaging and minimally invasive care pathways. NATO member states increasingly evaluate medical technology resilience, cybersecurity, data protection, and supply-chain continuity, especially for mission-critical imaging and interventional systems used across civilian and defense-linked healthcare settings.

Key Country Insights

The United States leads in adoption of advanced interventional suites, AI-enabled imaging, robotics-assisted workflows, and outpatient procedure migration, supported by extensive specialty networks and regulatory pathways for software-enabled medical devices. Canada emphasizes publicly funded access, quality, regional equipment planning, and equitable deployment across provinces, while Mexico and Brazil are expanding advanced care in metropolitan centers, creating opportunities for cost-effective platforms, managed service models, and workforce training.

In Europe, the United Kingdom, Germany, France, Italy, and Spain represent mature demand for hybrid operating rooms, interventional oncology, neurovascular procedures, and cardiovascular guidance, supported by established specialist societies and hospital modernization initiatives. Germany’s engineering and hospital infrastructure base, France’s public hospital networks, the United Kingdom’s digital health agenda, and Italy and Spain’s regional healthcare systems shape procurement priorities around clinical evidence, interoperability, service reliability, and cost control. Russia’s market is influenced by local sourcing, healthcare modernization priorities, and access considerations for advanced imaging and interventional technologies.

China is scaling domestic and imported systems across large hospital networks, supported by hospital construction, cancer care expansion, and growing interventional procedure capacity. India is driven by private hospital expansion, high cardiovascular and cancer burden, and affordability needs that favor versatile platforms and service-based models. Japan prioritizes precision, reliability, and aging-care capacity, making advanced image-guided therapy important for minimally invasive treatment of complex conditions. Australia benefits from high-quality specialist care, public-private healthcare access, and established imaging standards, while South Korea remains a strong adopter of digital hospitals, advanced imaging, and technology-enabled procedural workflows.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that combine imaging performance, workflow automation, radiation dose management, cybersecurity, and modular upgrade pathways. Vendors can strengthen competitiveness by offering interoperable systems aligned with DICOM, HL7, and FHIR standards and by supporting hybrid deployments across hospital, ambulatory, and specialty care settings.

Executives should invest in evidence generation that links image-guided therapy systems to clinical outcomes, procedure efficiency, length-of-stay reduction, lower complication rates, and improved resource utilization. Successful strategies should include AI governance, clinician training, remote service capabilities, lifecycle financing, local regulatory expertise, and partnerships with clinical institutions to validate next-generation interventional workflows.

Research Methodology

This executive summary is built on a secondary research framework that synthesizes publicly available data from regulatory agencies, health authorities, peer-reviewed literature, standards bodies, hospital technology trends, and clinical technology adoption indicators. The methodology emphasizes triangulation across clinical demand drivers, technology adoption indicators, reimbursement dynamics, regional infrastructure, regulatory requirements, and competitive positioning.

The analysis considers established sources such as the World Health Organization, U.S. Food and Drug Administration, OECD health statistics, national health ministries, industry standards organizations, and published clinical evidence on minimally invasive and image-guided procedures. Insights are evaluated for consistency, recency, and relevance to procurement, innovation, regulatory readiness, and commercialization decisions in image-guided therapy systems.

Conclusion

Image-guided therapy systems are moving from advanced imaging assets to intelligent procedural ecosystems that support safer, faster, and more precise interventions. The sector is being shaped by disease burden, aging populations, specialist demand, healthcare digitization, regulatory scrutiny, and the growing role of AI in clinical workflow optimization.

Organizations that align product development with interoperability, evidence-based outcomes, cybersecurity, regulatory readiness, and regional access models will be best positioned for sustainable expansion. As care delivery shifts toward minimally invasive, data-driven, and patient-centered interventions, image-guided therapy systems will remain a strategic priority for hospitals, medtech manufacturers, investors, and healthcare policymakers.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Image-guided Therapy System Market, by Product
7.1. Hardware
7.2. Services
7.3. Software
7.3.1. Image Processing Software
7.3.2. Navigation Software
7.3.3. Workflow Management Software
8. Image-guided Therapy System Market, by Imaging Modality
8.1. Cone Beam CT
8.2. Fluoroscopy
8.3. MRI
8.4. Ultrasound
9. Image-guided Therapy System Market, by Therapy Type
9.1. Minimally Invasive
9.1.1. Endoscopic
9.1.2. Laparoscopic
9.1.3. Robotic
9.2. Open Surgery
10. Image-guided Therapy System Market, by Application
10.1. Cardiovascular
10.2. Gastroenterology
10.3. Neurology
10.4. Oncology
10.5. Orthopedics
10.6. Urology
11. Image-guided Therapy System Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Hospitals
11.3. Imaging Centers
11.4. Specialty Clinics
12. Asia-Pacific Image-guided Therapy System Market
13. North America Image-guided Therapy System Market
14. Latin America Image-guided Therapy System Market
15. Europe Image-guided Therapy System Market
16. Middle East Image-guided Therapy System Market
17. Africa Image-guided Therapy System Market
18. ASEAN Image-guided Therapy System Market
19. GCC Image-guided Therapy System Market
20. European Union Image-guided Therapy System Market
21. BRICS Image-guided Therapy System Market
22. G7 Image-guided Therapy System Market
23. NATO Image-guided Therapy System Market
24. United States Image-guided Therapy System Market
25. Canada Image-guided Therapy System Market
26. Mexico Image-guided Therapy System Market
27. Brazil Image-guided Therapy System Market
28. United Kingdom Image-guided Therapy System Market
29. Germany Image-guided Therapy System Market
30. France Image-guided Therapy System Market
31. Russia Image-guided Therapy System Market
32. Italy Image-guided Therapy System Market
33. Spain Image-guided Therapy System Market
34. China Image-guided Therapy System Market
35. India Image-guided Therapy System Market
36. Japan Image-guided Therapy System Market
37. Australia Image-guided Therapy System Market
38. South Korea Image-guided Therapy System Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Accuray, Inc.
40.2. Analogic Corporation
40.3. Brainlab AG
40.4. Canon Medical Systems Corporation
40.5. Cook Medical, Inc.
40.6. Elekta AB
40.7. GE HealthCare Technologies Inc.
40.8. Hologic, Inc.
40.9. IMRIS, Inc.
40.10. Johnson & Johnson
40.11. Konica Minolta, Inc.
40.12. Koninklijke Philips N.V.
40.13. Medtronic plc
40.14. Olympus Corporation
40.15. RaySearch Laboratories AB
40.16. Shimadzu Corporation
40.17. Siemens Healthineers AG
40.18. Smith & Nephew plc
40.19. Stryker Corporation
40.20. Terumo Corporation
40.21. Varian Medical Systems, Inc.
40.22. Ziehm Imaging GmbH
40.23. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMAGE PROCESSING SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMAGE PROCESSING SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMAGE PROCESSING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NAVIGATION SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NAVIGATION SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NAVIGATION SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL WORKFLOW MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL WORKFLOW MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL WORKFLOW MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CONE BEAM CT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CONE BEAM CT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CONE BEAM CT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FLUOROSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FLUOROSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FLUOROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MRI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MRI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ENDOSCOPIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ENDOSCOPIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ENDOSCOPIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL LAPAROSCOPIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL LAPAROSCOPIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL LAPAROSCOPIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ROBOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ROBOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ROBOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ORTHOPEDICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ORTHOPEDICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ORTHOPEDICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL UROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 114. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 116. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 117. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 130. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 131. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 132. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 133. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 134. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. AFRICA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 138. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 139. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 140. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 141. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 142. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. ASEAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 146. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 147. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 148. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 149. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 150. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. GCC IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 162. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 163. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 164. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 165. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 166. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. BRICS IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 170. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 171. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 172. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 173. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 174. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. G7 IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 178. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 179. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 180. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 181. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 182. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. NATO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 194. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 195. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 196. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 197. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 198. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. CANADA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 201. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 202. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 203. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 204. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 205. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 206. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. MEXICO IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 210. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 211. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 212. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 213. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 214. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. BRAZIL IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 217. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 218. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 219. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 220. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 221. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 222. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. UNITED KINGDOM IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 225. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 226. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 227. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 228. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 229. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 230. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. GERMANY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 234. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 235. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 236. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 237. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 238. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. FRANCE IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 241. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 242. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 243. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 244. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 245. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 246. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. RUSSIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 249. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 250. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 251. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 252. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 253. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 254. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. ITALY IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 258. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 259. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 260. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 261. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 262. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. SPAIN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 265. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 266. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 267. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 268. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 269. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 270. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 271. CHINA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 273. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 274. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 275. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 276. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 277. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 278. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. INDIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 282. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 283. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 284. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 285. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 286. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. JAPAN IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 289. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 290. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 291. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 292. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 293. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 294. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 295. AUSTRALIA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 296. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 297. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 298. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 299. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 300. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 301. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 302. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 303. SOUTH KOREA IMAGE-GUIDED THERAPY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Image-guided Therapy System market report include:
  • Accuray, Inc.
  • Analogic Corporation
  • Brainlab AG
  • Canon Medical Systems Corporation
  • Cook Medical, Inc.
  • Elekta AB
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • IMRIS, Inc.
  • Johnson & Johnson
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Olympus Corporation
  • RaySearch Laboratories AB
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Varian Medical Systems, Inc.
  • Ziehm Imaging GmbH
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.53 Billion
Forecasted Market Value ( USD ) by 2032 $ 8.64 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Image-Guided Therapy Systems - Global Strategic Business Report - Product Image

Image-Guided Therapy Systems - Global Strategic Business Report

  • Report
  • 240 Pages
  • Global
From
Image-Guided Therapy Systems Market Report 2026 - Product Image

Image-Guided Therapy Systems Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Image-guided Therapy Systems Market Report by Product, Application, End Use, Countries and Companies Analysis 2026-2034 - Product Image

Image-guided Therapy Systems Market Report by Product, Application, End Use, Countries and Companies Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Image Guided Radiation Therapy System Market - Global Forecast 2025-2030 - Product Image

Image Guided Radiation Therapy System Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Breast Biopsy Market - Global Forecast 2026-2032 - Product Image

Breast Biopsy Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From

About the Image Guided Therapy Market

The Image Guided Therapy market is a subset of the Medical Imaging industry. It is focused on the use of imaging technologies to guide therapeutic procedures, such as surgery, radiation therapy, and interventional radiology. This market is driven by the need for more precise and accurate treatments, as well as the increasing availability of imaging technologies. Image Guided Therapy is used to improve the accuracy of treatments, reduce the risk of complications, and improve patient outcomes. The Image Guided Therapy market is composed of a variety of companies, including those that develop and manufacture imaging technologies, those that provide services related to the use of imaging technologies, and those that develop software and applications for image-guided therapies. Examples of companies in this market include GE Healthcare, Philips Healthcare, Siemens Healthineers, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.